StayHappi Bromocriptine 0.8mg Tablet is a medicine used in the treatment of type 2 diabetes mellitus. It is generally used as an add-on to diet and exercise to improve glycemic control. It helps in reducing insulin resistance and provides better control over blood sugar levels in people with type 2 diabetes mellitus.

is used to treat Parkinson's disease (a disorder of the nervous system that causes difficulties with movement and balance) and also has multiple other actions

Uses of StayHappi Tablet

Female infertility

Benefits of StayHappi Tablet

In Female infertility

StayHappi Bromocriptine 0.8mg Tablet helps in the regulation of ovulation and menstruation. It is used to cause menstrual periods in women who have not reached menopause but are not having periods due to too much prolactin hormone in the body. Use the medicine as prescribed for it to be effective.

Side effects of StayHappi Tablet

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of StayHappi

Nausea
Headache
Dizziness
Fatigue
Constipation
Inflammation of the nose
Weakness

How to use StayHappi Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. StayHappi Bromocriptine 0.8mg Tablet is to be taken with food.

How StayHappi Tablet works

StayHappi Bromocriptine 0.8mg Tablet is a dopamine receptor agonist. It is used in the treatment of Type 2 diabetes. It helps in reducing insulin resistance and provide better control over blood sugar level.

Safety advice

Alcohol

UNSAFE

StayHappi Bromocriptine 0.8mg Tablet may cause excessive drowsiness with alcohol.

Pregnancy

SAFE IF PRESCRIBED

StayHappi Bromocriptine 0.8mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.

Breast feeding

CONSULT YOUR DOCTOR

StayHappi Bromocriptine 0.8mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
StayHappi Bromocriptine 0.8mg Tablet is usually not used during breastfeeding because it suppresses lactation.

Driving

UNSAFE

StayHappi Bromocriptine 0.8mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

Kidney

CAUTION

StayHappi Bromocriptine 0.8mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of StayHappi Bromocriptine 0.8mg Tablet may be needed. Please consult your doctor.

Liver

CAUTION

StayHappi Bromocriptine 0.8mg Tablet should be used with caution in patients with liver disease. Dose adjustment of StayHappi Bromocriptine 0.8mg Tablet may be needed. Please consult your doctor.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

StayHappi Bromocriptine 0.8mg Tablet

₹4.67/Tablet

D-Bro 0.8mg Tablet

Zyphar's Pharmaceuticals Pvt Ltd

₹7.6/tablet

63% costlier

Diacriptin 0.8mg Tablet

Delvin Formulations Pvt Ltd

₹7.6/tablet

63% costlier

Brainstar 0.8mg Tablet

USV Ltd

₹6.19/tablet

33% costlier

Glucomind 0.8mg Tablet

Lupin Ltd

₹6.6/tablet

41% costlier

Bromitine 0.8mg Tablet

East West Pharma

₹5.19/tablet

11% costlier

Quick tips

StayHappi Bromocriptine 0.8mg Tablet is used to lower blood sugar level in adults with type 2 diabetes.
You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines (if prescribed) along with StayHappi Bromocriptine 0.8mg Tablet.
It should be taken with or after food to avoid side effects such as nausea or indigestion.
To lower the chance of feeling dizzy or passing out, rise slowly if you have been sitting or lying down.
Use caution while driving or doing anything that requires concentration as StayHappi Bromocriptine 0.8mg Tablet can cause dizziness and sleepiness.
Hypoglycemia (low blood sugar level) may occur when taken along with other antidiabetic medicines, alcohol or on delaying/skipping a meal. Carry a sugar source with you for immediate relief.

Fact Box

Chemical Class

Ergolines

Habit Forming

Therapeutic Class

NEURO CNS

Action Class

Dopamine agonists-Hyperprolactinemia

Patient concerns

My infertility in 5min my dots Plz my infertility problem

Dr. Sonu Balhara Ahlawat

Obstetrics and Gynaecology

cant understand ur problem

Sperm infertility problem. It will be no infertility for sperm

Dr. Praveen Pushkar

Urology

I could not get u

Infertility problem. Taking treatment since may13. Did all test, iui, laparoscopy. said it's unexplained infertility.

Dr. Megha Gupta

Obstetrics and Gynaecology

Hi PATIENT to 1mgd0ctors. Dorry to hear about your problem. Unexplained infertility is rising rapidly these days due to the high stress levels in our lives. I would suggest you continue taking treatment and I'm sure you will get a good news soon. All the best. Let me know if i can assist you in any way.

Related lab tests

Anti Mullerian Hormone

Glycosylated Hemoglobin

Testosterone Total

Thyroid Stimulating Hormone

Top Physicians

4.9 ★

4.1 ★

4.2 ★

4.1 ★

4.5 ★

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Parker KL, Schimmer BP. Introduction To Endocrinology: The Hypothalamic-Pituitary Axis. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1114.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 160-61.
Garg KK, Chugh SN. Bromocriptin mesylate in type 2 diabetes mellitus: A novel approach. International Journal of Medical Science and Public Health. 2017;6(6). [Accessed 18 Jan. 2019] (online) Available at:
Bromocriptine. Tiverton, Rhode Island: VeroScience; 1978 [revised Oct. 2015]. [Accessed 03 Apr. 2019] (online) Available from:
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198. [Accessed 03 Apr. 2019] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). [Accessed 04 Apr. 2019] (online) Available from:

Marketer details

Name: Sarvagunaushdhi Pvt Ltd

Address: 13Th Floor, Pearl Best Hight-1, Netaji Subhash Place, Pitampura, Delhi North Delhi DL 110034 IN

Country of origin: India

The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.